Plant derived VLP for COVID-19 / Shiraz University - LARVOL DELTA

Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2. (PubMed, Biotechnol Lett) - "Plant-based VLP-based viral vaccines currently in clinical trials include, amongst others, Hepatitis B virus, Influenza virus and SARS-CoV-2 vaccines. Here we discuss the importance of plants as a next generation expression system for the fast, scalable and low cost production of VLP-based vaccines."

Journal • Review • Hepatitis B • Hepatology • Infectious Disease • Inflammation • Novel Coronavirus Disease • Respiratory Diseases